Richard Hague
Chief Executive Officer bei REGENETP, INC.
Vermögen: 4 445 $ am 31.03.2024
Profil
Richard Hague is currently the President, Chief Executive Officer & Director at RegenETP, Inc. He is also the Chief Executive Officer at PolarityTE MD, Inc. Previously, he held positions as the Senior Director at Genzyme Biosurgery Corp.
from 2001 to 2005, the Chief Commercial Officer at Anika Therapeutics, Inc. from 2015 to 2019, the Vice President-Sales & Marketing at TEI Medical, Inc. from 2004 to 2015, and the VP-Sales, Marketing & Commercial Operations at Sanofi UK from 2011 to 2014.
Mr. Hague obtained his undergraduate degree from the University of Connecticut.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
REGENETP INC.
0,60% | 20.03.2023 | 44 453 ( 0,60% ) | 4 445 $ | 31.03.2024 |
Aktive Positionen von Richard Hague
| Unternehmen | Position | Beginn |
|---|---|---|
| REGENETP, INC. | Chief Executive Officer | 01.09.2021 |
PolarityTE MD, Inc.
 PolarityTE MD, Inc. BiotechnologyHealth Technology PolarityTE MD, Inc. operates as a biotechnology company, which develops and commercializes regenerative tissue products and biomaterials. The company was founded on November 23, 2016 and is headquartered in Salt Lake City, UT. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Richard Hague
| Unternehmen | Position | Ende |
|---|---|---|
| ANIKA THERAPEUTICS, INC. | Corporate Officer/Principal | 05.04.2019 |
TEI Medical, Inc.
 TEI Medical, Inc. BiotechnologyHealth Technology Part of Integra LifeSciences Holdings Corp., TEI Medical, Inc. provides an ideal environment to support cellular repopulation and revascularization processes. The private company is based in Waltham, MA. TEI Medical was acquired by Integra LifeSciences Holdings Corp. on July 17, 2015 for $101 million. | Sales & Marketing | 01.10.2015 |
Sanofi UK
 Sanofi UK Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi UK is a private company that manufactures and markets healthcare products. The company is based in Guildford, UK. | Sales & Marketing | 01.01.2014 |
Genzyme Biosurgery Corp.
 Genzyme Biosurgery Corp. BiotechnologyHealth Technology Genzyme Biosurgery develops and manufactures bio-therapeutic and bio-material products. Its products include Osteoarthritis Relief, Adhesion Prevention, Cartilage Repair, Severe Burn Treatment, and Bulk HA Platform. The company is headquartered in Cambridge, MA. | Director/Board Member | 01.01.2005 |
Ausbildung von Richard Hague
| University of Connecticut | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ANIKA THERAPEUTICS, INC. | Health Technology |
| REGENETP, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Genzyme Biosurgery Corp.
Genzyme Biosurgery Corp. BiotechnologyHealth Technology Genzyme Biosurgery develops and manufactures bio-therapeutic and bio-material products. Its products include Osteoarthritis Relief, Adhesion Prevention, Cartilage Repair, Severe Burn Treatment, and Bulk HA Platform. The company is headquartered in Cambridge, MA. | Health Technology |
TEI Medical, Inc.
TEI Medical, Inc. BiotechnologyHealth Technology Part of Integra LifeSciences Holdings Corp., TEI Medical, Inc. provides an ideal environment to support cellular repopulation and revascularization processes. The private company is based in Waltham, MA. TEI Medical was acquired by Integra LifeSciences Holdings Corp. on July 17, 2015 for $101 million. | Health Technology |
Sanofi UK
Sanofi UK Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi UK is a private company that manufactures and markets healthcare products. The company is based in Guildford, UK. | Health Technology |
PolarityTE MD, Inc.
PolarityTE MD, Inc. BiotechnologyHealth Technology PolarityTE MD, Inc. operates as a biotechnology company, which develops and commercializes regenerative tissue products and biomaterials. The company was founded on November 23, 2016 and is headquartered in Salt Lake City, UT. | Health Technology |
